インスリン送達機器の世界市場:インスリン注射器、インスリン・ポンプ、インスリン・ペン、インスリン・ジェット式注射器

◆英語タイトル:Global Insulin Delivery Systems Market 2016-2020
◆商品コード:IRTNTR9770
◆発行会社(調査会社):Technavio
◆発行日:2016年8月26日
◆ページ数:81
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、インスリン送達機器の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、インスリン送達機器の世界市場規模及び予測、製品別分析、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About Insulin
The cost of syringes and insulin pens is low, which enables users to opt for them as first choice devices. High cost of insulin pumps and insulin jet injectors poses a challenge to the growth of the market. Insulin pumps and jet injectors also require special care and maintenance, which is an additional cost burden to patients.

Technavio’s analysts forecast the global insulin delivery systems market to grow at a CAGR of 5.11% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global insulin delivery systems market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of insulin delivery systems.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Insulin Delivery Systems Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Novo Nordisk
• Sanofi
• BD
• Eli Lilly
• Medtronic

[Other prominent vendors]
• Animas
• Beta Bionics
• Cellnovo
• Copernicus
• Dance Biopharm
• Debiotech
• InsuJet
• Insulet
• MannKind
• Owen Mumford
• Roche
• SHL
• SOOIL
• Tandem Diabetes Care
• Valeritas
• West Pharma
• Ypsomed

[Market driver]
• Paradigm shift of patient pool from hospitals to specialty clinics
• For a full, detailed list, view our report

[Market challenge]
• High cost of insulin devices and competitive pricing scenario
• For a full, detailed list, view our report

[Market trend]
• Inhalers to revolutionize insulin delivery
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by product
• Global insulin syringes market
• Global insulin pumps market
• Global insulin pens market
• Global insulin jet injectors market

PART 07: Market segmentation by end-user
• Hospitals
• Specialty diabetic clinics
• Retail channels

PART 08: Geographical segmentation
• Insulin delivery systems market in Americas
• Insulin delivery systems market in EMEA
• Insulin delivery systems market in APAC

PART 09: Market drivers
• Increase in type-1 diabetes
• Paradigm shift of patient pool from hospitals to specialty clinics
• Focus on self-management of diabetes

PART 10: Impact of drivers

PART 11: Market challenges
• High cost of insulin devices and competitive pricing scenario
• Threat of substitutes
• Budget restrictions and stringent reimbursement policies
• Complications and unmet needs

PART 12: Impact of drivers and challenges

PART 13: Market trends
• Inhalers to revolutionize insulin delivery
• Disruptive technologies
• Strategic alliances leading to innovative insulin delivery systems

PART 14: Vendor landscape
• Competitive scenario
• Recent developments

PART 15: Key vendor analysis
• Novo Nordisk
• Sanofi
• BD
• Eli Lilly
• Medtronic
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

PART 17: Explore Technavio

[List of Exhibits]

Exhibit 01: Global insulin delivery systems market
Exhibit 02: Segment overview
Exhibit 03: Product offerings
Exhibit 04: Global insulin delivery systems market 2015-2020 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Product lifecycle of insulin delivery systems
Exhibit 07: Global insulin delivery systems market by product 2015
Exhibit 08: Global insulin delivery systems market by product 2020
Exhibit 09: Global insulin syringes market: Opportunity analysis
Exhibit 10: Global insulin syringes market: Metric analysis
Exhibit 11: Global insulin syringes market 2015-2020 ($ billions)
Exhibit 12: Global insulin pumps market: Opportunity analysis
Exhibit 13: Global insulin pumps market: Metric analysis
Exhibit 14: Global insulin pumps market 2015-2020 ($ billions)
Exhibit 15: Factors considered for making an ideal pen
Exhibit 16: Global insulin pens market: Opportunity analysis
Exhibit 17: Global insulin pens market: Metric analysis
Exhibit 18: Global insulin pens market 2015-2020 ($ billions)
Exhibit 19: Global insulin jet injectors market: Opportunity analysis
Exhibit 20: Global insulin jet injectors market: Metric analysis
Exhibit 21: Global insulin jet injectors market 2015-2020 ($ billions)
Exhibit 22: Global insulin delivery systems market by geography 2015
Exhibit 23: Global insulin delivery systems market by geography 2020
Exhibit 24: Global insulin delivery systems market by geography 2015-2020
Exhibit 25: Comparative study of diabetic population (0-14 years) in specific countries in Americas 2013 and 2015
Exhibit 26: Insulin delivery systems market in Americas 2015-2020 ($ billions)
Exhibit 27: Comparative study of diabetic population (0-14 years) in selected European countries 2013 and 2015
Exhibit 28: Comparative study of diabetic population (0-14 years) in selected MEA countries 2013 and 2015
Exhibit 29: Insulin delivery systems market in EMEA 2015-2020 ($ billions)
Exhibit 30: Insulin delivery systems market in APAC 2015-2020 ($ billions)
Exhibit 31: Comparison of type 1 diabetes incidences 2013 and 2015
Exhibit 32: Impact of drivers
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Global insulin delivery systems market: Competitive landscape 2015
Exhibit 35: Recent developments
Exhibit 36: Ranking of vendors 2015
Exhibit 37: Novo Nordisk: Metric analysis
Exhibit 38: Sanofi: Metric analysis
Exhibit 39: BD: Metric analysis
Exhibit 40: Eli Lilly: Metric analysis
Exhibit 41: Medtronic: Metric analysis
Exhibit 42: Other prominent vendors



【掲載企業】

Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Animas, Beta Bionics, Cellnovo, Copernicus, Dance Biopharm, Debiotech, InsuJet¸ Insulet, MannKind, Owen Mumford, Roche¸ SHL, SOOIL, Tandem Diabetes Care, Valeritas, West Pharma¸ and Ypsomed.

【レポートのキーワード】

インスリン送達機器、インスリン注入器、インスリン注射器、インスリン・ポンプ、インスリン・ペン、インスリン・ジェット式注射器

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[インスリン送達機器の世界市場:インスリン注射器、インスリン・ポンプ、インスリン・ペン、インスリン・ジェット式注射器]販売に関する免責事項
★調査レポート[インスリン送達機器の世界市場:インスリン注射器、インスリン・ポンプ、インスリン・ペン、インスリン・ジェット式注射器]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆